Prominence of IL6, IGF, TLR, and Bioenergetics Pathway Perturbation in Lung Tissues of Scleroderma Patients With Pulmonary Fibrosis.

Renaud, Ludivine; da Silveira, Willian A; Takamura, Naoko; Hardiman, Gary; Feghali-Bostwick, Carol

Renaud, Ludivine; da Silveira, Willian A; Takamura, Naoko; Hardiman, Gary; Feghali-Bostwick, Carol.

Affiliation

Renaud L; Department of Medicine, Medical University of South Carolina, Charleston, SC, United States.
da Silveira WA; School of Biological Sciences, Institute for Global Food Security, Queens University Belfast, Belfast, United Kingdom.
Takamura N; Department of Medicine, Medical University of South Carolina, Charleston, SC, United States.
Hardiman G; Department of Medicine, Medical University of South Carolina, Charleston, SC, United States.
Feghali-Bostwick C; School of Biological Sciences, Institute for Global Food Security, Queens University Belfast, Belfast, United Kingdom.

Front Immunol ; 11: 383, 2020.

Article de En | MEDLINE | ID: mdl-32210969

Sujet(s)
Mots clés

idiopathic; interstitial lung disease; microarray; pulmonary fibrosis; scleroderma; systemic sclerosis

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Basidiomycota / Facteur de croissance IGF-I / Interleukine-6 / Fibrose pulmonaire idiopathique / Poumon / Mycoses Type d'étude: Prognostic_studies Limites: Humans Langue: En Journal: Front Immunol Année: 2020 Type de document: Article Pays d'affiliation: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google